| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091480 Antigen-Binding Proteins Targeting S. Aureus Orf0657n |
| 04/21/2011 | US20110091477 Modulators of hepatocyte growth factor activator |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091437 Fusion proteins |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091416 Immunoglobulin fusion proteins |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091386 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | CA2777738A1 Enzyme method of extracting oils and proteins from vegetable matter in an aqueous medium |
| 04/21/2011 | CA2776392A1 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311972A1 Recombinant N-glycosylated proteins from procaryotic cells |
| 04/20/2011 | EP2311962A1 Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides |
| 04/20/2011 | EP2311956A1 Methods for making APO-2 ligand using divalent metal ions |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311947A1 Protein synthesis via click chemistry |
| 04/20/2011 | EP2311946A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 04/20/2011 | EP2311943A2 Factor VII glycoforms |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311864A1 Recombinant protein-s composition |
| 04/20/2011 | EP2311484A1 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 04/20/2011 | EP2310523A1 Methods for enhanced production of bone morphogenetic proteins |
| 04/20/2011 | EP2310511A1 Self-replicating vector lacking an antibiotic-resistance gene |
| 04/20/2011 | EP1697509B1 Processing of peptides and proteins |
| 04/20/2011 | EP1556480B1 Method for isolating and culturing unculturable microorganisms |
| 04/20/2011 | EP1539989B1 Synthesis of oligosaccharides, glycolipids and glycoproteins using bacterial glycosyltransferases |
| 04/20/2011 | EP1451223B1 Expression control using variable intergenic sequences |
| 04/20/2011 | EP1227159B1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 04/20/2011 | CN1852984B A non-denaturing process to purify recombinant proteins from plants |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN1701117B Antibody against enzyme specifically cleaving VON WILLEBRAND factor and assay system using the same |
| 04/20/2011 | CN1628179B Detection of hepatocellular carcinoma |
| 04/20/2011 | CN1551918B Genetically modified ecarin and process for producing the same |
| 04/20/2011 | CN102027110A Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
| 04/20/2011 | CN102026648A Pharmaceutical composition for treatment of dry eye and/or corneal/conjunctival disorders |
| 04/20/2011 | CN102021217A Method for high efficient expression of monoclonal antibody by means of animal cell fed-batch culture |
| 04/20/2011 | CN102021216A Extraction method of antialcoholism peptide |
| 04/20/2011 | CN102021215A Method for extracting gelatin peptides |
| 04/20/2011 | CN102021196A Method for producing recombinant human interleukin-21 by using Pichia pastoris |
| 04/20/2011 | CN102021195A Method for efficiently preparing protein molecular weight standard by utilizing prokaryotic expression system |
| 04/20/2011 | CN102021193A Method for producing polypeptide by combining biological expression of protein with chemical cracking technique |
| 04/20/2011 | CN102021184A Antigenic polypeptides |
| 04/20/2011 | CN102021175A Optimized grass carp alpha interferon encoding gene and application thereof |
| 04/20/2011 | CN102021171A Method for optimizing and efficiently expressing genes of S100A4 protein |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102021125A Organic solvent resistant protease producing strain, gene of organic solvent resistant protease produced thereby and application of organic solvent resistant protease |
| 04/20/2011 | CN102020856A Method for recovering glucomannan and protein in konjac flying powder by enzyme process |
| 04/20/2011 | CN102020716A Gene recombination human collagen fusion peptide segment, preparation method and application thereof |
| 04/20/2011 | CN102020710A Novel mutant EN-46 of human epidermal growth factor |
| 04/20/2011 | CN102018726A Method for preparing animal hoof nail extract |
| 04/20/2011 | CN101560506B Process for preparing catalase and hepatocyte growth-promoting decoction simultaneously by taking animal liver as raw material |
| 04/20/2011 | CN101555477B Heavy and light chain variable region gene of monoclonal antibody resisting human amyloid protein, and its uses |
| 04/20/2011 | CN101302251B Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof |
| 04/19/2011 | US7930107 Methods of generating variant proteins with increased host string content |
| 04/19/2011 | US7928285 Method of producing xenogenous antibodies using a bovine |
| 04/19/2011 | US7928213 Nucleic acids encoding chimeric CD154 polypeptides |
| 04/19/2011 | US7928201 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/19/2011 | US7928199 Stabilized proteins with engineered disulfide bonds |
| 04/19/2011 | US7928198 IL-B50 polypeptide |
| 04/19/2011 | US7928195 Poly zinc finger proteins with improved linkers |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7928072 Multimeric constructs |
| 04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 04/19/2011 | US7927863 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 04/19/2011 | US7927859 High molar succinate yield bacteria by increasing the intracellular NADH availability |
| 04/19/2011 | US7927836 Device and method for the production of biologically active compounds by fermentation |
| 04/19/2011 | US7927835 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 04/19/2011 | US7927834 Recombinant production of mixtures of antibodies |
| 04/19/2011 | US7927832 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 04/19/2011 | US7927831 Anti HIV-1 bacterial and baculovirus recombinant Epap-1 |
| 04/19/2011 | US7927817 Hybrid antibodies |
| 04/19/2011 | US7927815 Varying hydrogen ion concentration of mixture in order to remove contaminating DNA sequences; recovering antibodies from solution |
| 04/19/2011 | US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 04/19/2011 | US7927803 Human MutY |
| 04/19/2011 | US7927793 Cell lines and host nucleic acid sequences related to infectious disease |
| 04/19/2011 | US7927786 Parkin interacting polypeptides and methods of use |
| 04/19/2011 | US7927607 S. agalactiae antigens I and II |
| 04/19/2011 | US7927594 Monoclonal antibody 9TL that comprises an Fc region having impaired effector function; treating a disease characterized by aberrant deposition of a protein in the brain of a subject; Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy |
| 04/19/2011 | US7927583 Receptor based antagonists and methods of making and using |
| 04/19/2011 | CA2451680C Human dr4 antibodies and uses thereof |
| 04/19/2011 | CA2421258C Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 04/19/2011 | CA2362496C Polypeptide variants with increased heparin-binding ability |
| 04/19/2011 | CA2220116C Dna encoding glutamate gated chloride channels |
| 04/19/2011 | CA2195090C Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 04/19/2011 | CA2166117C Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/14/2011 | WO2011044368A1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
| 04/14/2011 | WO2011043385A1 Artificial base pair capable of forming specific base pair |
| 04/14/2011 | WO2011022077A3 A nucleic acid cassette for producing recombinant antibodies |